US FDA OKs monthly maintenance dosing for Eisai/Biogen’s Alzheimer’s drug
(Reuters) – The U.S. Food and Drug Administration has approved monthly maintenance dosing for Japan’s Eisai and partner Biogen (NASDAQ:BIIB)’s Alzheimer’s drug
(Reuters) – The U.S. Food and Drug Administration has approved monthly maintenance dosing for Japan’s Eisai and partner Biogen (NASDAQ:BIIB)’s Alzheimer’s drug
Investing.com– Natural gas firm Diversified Energy Company PLC (NYSE:DEC) is in advanced talks to buy Maverick Natural Resources- a private equity owned
By Jack Kim SEOUL (Reuters) – South Korea’s authorities investigating last month’s Jeju Air plane crash have submitted a preliminary accident report to
(Reuters) – Perplexity AI revised the merger proposal it had submitted to TikTok parent ByteDance, CNBC reported on Sunday. The proposal, to create
By Abhirup Roy PALO ALTO, California (Reuters) -A joint venture between U.S. electric pickup and SUV maker Rivian (NASDAQ:RIVN) and Volkswagen (ETR:VOWG_p) is
(Reuters) – Universal Music Group (AS:UMG), the world’s biggest music label, and Swedish streaming giant Spotify (NYSE:SPOT) have reached a new multi-year
By Humeyra Pamuk, Maggie Michael and Lena Masri WASHINGTON (Reuters) – The Trump administration urged U.S. Agency for International Development (USAID) workers to
Investing.com – Saudi Arabia stocks were higher after the close on Sunday, as gains in the Real Estate Development, Hotels & Tourism
(Reuters) – Diageo (LON:DGE) does not intend to sell its beer brand Guinness or its stake in Moet Hennessy, LVMH’s
Investing.com — Donald Trump’s presidential victory raised fears that the U.S. was on a unavoidable path toward another trade war with China,